Skip to content

Telephone Monitoring of Blood Cancer Patients in outpatient Chemotherapy: proposal for an assistance protocol

Telephone monitoring of onco-hematological patients undergoing outpatient chemotherapy: proposal for an assistance protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-544pfq
Enrollment
Unknown
Registered
2020-08-05
Start date
2019-06-06
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Other and unspecified types of non-Hodgkin's lymphoma

Interventions

Experimental group: 12 participants diagnosed with lymphoma who received telephone follow up in D2, D8 and D15 after the chemotherapy session. Control group: 12 participants diagnosed with lymphoma wh
Other
SP2.021.167.010.090.020

Sponsors

Universidade Federal Fluminense
Lead Sponsor
Instituto Nacional de Câncer
Collaborator

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Medical diagnosis of Lymphoma that would initiate first-line outpatient chemotherapy treatment regimen: International Disease Code (ICD-10) for Non-Hodgkin's Lymphoma and its classifications (C82 to C85) and Hodgkin's Lymphoma and its classifications (C81), absence of previous chemotherapy treatment and who had Karnofsky Perfomance Status (KPS) or Zubrod Scale (ECOG) between 70% to 100% or 0-1 (Appendix A) (90-1), respectively, assessed by the doctor and the nurse at the first consultation turn; patients aged 18 to 64 years and have a fixed or mobile phone.

Exclusion criteria

Exclusion criteria: Presence of cognitive deficit and / or change in physical conditions that make participation in the research and hearing deficit unfeasible.

Design outcomes

Primary

MeasureTime frame
It is expected to find a lower intensity of signs and symptoms related to the disease and treatment in the intervention group when compared to the control group. Checked for variables based on the Commom Terminology Criteria for Adverse Effects (CTCAE) version 5.0.

Secondary

MeasureTime frame
It is expected to find greater satisfaction with care in the intervention group compared to the control group. Verified through a scale of 0 to 5 for the care offered by nurses - 0: nothing satisfied; 1: little satisfied; 2: reasonably satisfied; 3: satisfied; 4: very satisfied; 5: extremely satisfied - during chemotherapy treatment.

Countries

Brazil

Contacts

Public ContactIsadora Moretto

Instituto Nacional de Câncer

isaamoretto@hotmail.com+55-021-999418001

Outcome results

None listed

Source: REBEC (via WHO ICTRP)